Skip to content

Metoclopramide and serum therapy in control of vomiting in moderate dehydration due to Acute viral Gastroenteritis in children aged 1-7 years

Metoclopramide and serum therapy in control of vomiting in moderate dehydration due to Acute viral Gastroenteritis in children aged 1-7 years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201205159766N1
Enrollment
240
Registered
2012-07-14
Start date
2009-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute viral gastroenteritis. Other viral enteritis

Interventions

Intervention 1: addition of Metocloperamid 0.1 mg/kg to serum therapy in case group. Intervention 2: standard serum therapy for isonatremic moderate dehydration as described by Nelson textbook of pe
Treatment - Drugs
Treatment - Other
addition of Metocloperamid 0.1 mg/kg to serum therapy in case group
standard serum therapy for isonatremic moderate dehydration as described by Nelson textbook of pediatrics in addition to electrolyte correction in control group as below : maintenance water is calc

Sponsors

Vice chancellor for research, Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 7 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1-7 year old children with acute viral gastroenteritis; vomiting; moderate isonatremic dehydration; parenteral intolerance; no therapy prior to admission; no need for therapies other than those provided and written consent by parents. Exclusion criteria: mild or severe dehydration or hypo/hypernatremic moderate dehydration; laboratory results indicating active colitis e.g. blood , WBC or parasite in stool exam; acute abdomen symptomes or any emergency situation; gastro aesophageal reflux and patient discontinuation and/or premature dismiss.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Vomiting. Timepoint: everyday for 4 days. Method of measurement: by nurse.

Secondary

MeasureTime frame
Extrapyramidal symptomes. Timepoint: everyday for 4 days. Method of measurement: by nurse.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Frouzifar

Arak University of Medical Sciences

src@arakmu.ac.ir+98 86 1417 3502

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026